Treatment of CML in pediatric patients: Should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?
Michael A. PulsipherVolume:
43
Year:
2004
Language:
english
Pages:
11
DOI:
10.1002/pbc.20062
File:
PDF, 120 KB
english, 2004